← Leaderboards
Alex Nivorozhkin
Inotek Pharmaceuticals Corporation
$186,183
Attributed
$186,183
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$186,183 · 1
By mechanism
R43$186,183 · 1
Top collaborators
No co-investigators on record.
Most similar at Inotek Pharmaceuticals Corporation
Same institution · by research overlap
- Andrew L Salzman$19,918,828
- Garry John Southan$13,828,224
- Csaba Szabo$15,264,870
- Prakash Jagtap$6,029,479
- Zsuzsanna Kinga Zsengeller$1,107,155
Others in their field
Top investigators on “Allopurinol”
- Alessandro Doria · Joslin Diabetes Center$16,452,875
- S Michael Mauer · University Of Minnesota Twin Cities$16,452,875
- Jennifer J. Gassman · Cleveland Clinic Foundation$5,472,590
- Elizabeth Phillips · University Of Cape Town$3,609,049
- John P Forman · Brigham And Women'S Hospital$3,527,716
- John E Repine · University Of Colorado Denver$3,414,039
Research focus
AllopurinolCardiovascular AgentsCongestive Heart FailureDogsDrug Screening /EvaluationFree Radical OxygenHeart ContractionIntracardiac PressurePharmacokineticsSuperoxidesXanthine Oxidase Inhibitor